DAFTAR PUSTAKA

1. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al.

Global estimates of the prevalence and incidence of four curable sexually
transmitted infections in 2012 based on systematic review and global reporting.
PLos One 2015;10(12):e0143304

2. Forna F, Glmezoglu AM. Interventions for treating trichomoniasis in

women. Cochrane Database Syst Rev. 2003. CD000218. [Medline].

3. Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral
sexually transmitted infection receives the least public health attention. Clin Infect
Dis. 2007 Jan 1. 44(1):23-5. [Medline].

4. Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, et

al. The effect of treatment of vaginal infections on shedding of human
immunodeficiency virus type 1. J Infect Dis. 2001 Apr 1. 183(7):1017-
22. [Medline].

5. Soper D. Trichomoniasis: under control or undercontrolled?. Am J Obstet

Gynecol. 2004 Jan. 190(1):281-90. [Medline].

6. Francis SC, Kent CK, Klausner JD, Rauch L, Kohn R, Hardick A, et al.
Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male
patients at the San Francisco STD clinic, 2005-2006. Sex Transm Dis. 2008 Sep.
35(9):797-800. [Medline].

7. [Guideline] Workowski KA, Berman SM. Sexually transmitted diseases treatment

guidelines, 2006. MMWR Recomm Rep. 2006 Aug 4. 55:1-94. [Medline].

8. Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB, et al. Diagnosis
of trichomoniasis. Comparison of conventional wet-mount examination with
cytologic studies, cultures, and monoclonal antibody staining of direct
specimens. JAMA. 1988 Feb 26. 259(8):1223-7. [Medline].
9. Radonjic IV, Dzamic AM, Mitrovic SM, Arsic Arsenijevic VS, Popadic DM,
Kranjcic Zec IF. Diagnosis of Trichomonas vaginalis infection: The sensitivities
and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol
Reprod Biol. 2006 May 1. 126(1):116-20. [Medline].

10. Centers for Disease Control and Prevention. Sexually Transmitted Diseases
Treatment Guidelines, 2010: Diseases Characterized by Vaginal Discharge.
Centers for Disease Control and Prevention. Available
at http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a2. Accessed:
June 1, 2012.

11. Eckert J. Protozoa. In: Kayser FH, Bienz KA, Eckert J, et al, eds. Color Atlas of
Medical Microbiology. 2nd ed. New York, NY: Thieme; 2005:
12. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev. 2004 Oct.
17(4):794-803, table of contents. [Medline]. [Full Text].
13. Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Trichomonas vaginalis
among HIV-Infected women: are immune status or protease inhibitor use
associated with subsequent T. vaginalis positivity?. Sex Transm Dis. 2003 Nov.
30(11):839-43. [Medline].
14. Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, et al.
Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis.
1999 Aug. 26(7):381-7.[Medline].
15. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of
Trichomonas vaginalis. Clin Microbiol Rev. 1998 Apr. 11(2):300-
17. [Medline]. [Full Text].
16. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and
premature rupture of membranes: a prospective study of the vaginal flora in
pregnancy. Am J Obstet Gynecol. 1984; 150:965972. [PubMed: 6391179]
17. Schoonmaker JN, Lawellin DW, Lunt B, et al. Bacteria and inflammatory cells
reduce chorioamniotic membrane integrity and tensile strength. Obstet Gynecol.
1989; 74:590596. [PubMed: 2552366]
18. Carey JC, Yaffe SJ, Catz C. The Vaginal Infections and Prematurity Study: an
overview. Clin Obstet Gynecol. 1993; 36:809820. [PubMed: 8293583]
19. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent
preterm delivery among pregnant women with asymptomatic Trichomonas
vaginalis infection. N Engl J Med. 2001; 345:487493. [PubMed: 11519502]
20. al-Salihi FL, Curran JP, Wang J. Neonatal Trichomonas vaginalis: report of three
cases and review of the literature. Pediatrics. 1974; 53:196200. [PubMed:
4544183]
21. Smith LM, Wang M, Zangwill K, et al. Trichomonas vaginalis infection in a
premature newborn. J Perinatol. 2002; 22:502503. [PubMed: 12168131]
22. Trussell RE. Vaginal trichomoniasis, complement fixation, puerperal morbidity
and early infection of the newborn infants. Am J Obstet Gynecol. 1942; 44:292.
23. Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol.
2004; 190(1): 28190. [PubMed: 14749674]
24. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares
favorably with transcription-mediated amplification assay for the detection of
Trichomonas vaginalis in young women. Clin Infect Dis. 2007; 45(2):1948.
[PubMed: 17578778]
25. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male
sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect
Dis. 2007; 44:1322. [PubMed:17143809]
26. Centers for Disease Control and Prevention. Sexually transmitted diseases
treatment guidelines. MMWR. 2010; 59(No. RR-12):5861
27. Ginocchio CC, Chapin K, Smith JS, Aslanzadeh J, Snook J, Hill CS, Gaydos CA.
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis
and Neisseria gonorrhoeae in the United States as determined by the Aptima
Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol. 2012
Aug;50(8):2601-8.
28. Transmited Diseases and Common Syndromes: Lower Genital Infections in
Woman, Cecil Textbook of Medicine Ed.23nd, USA, 2004, Saunders
29. Diagnosis and TreatmentSexual Transmited Disease. Mc Graww Hill. Chapter
18. Hal 116-118
30. Global strategy for the prevention and control of sexually transmitted infections:
20062015. Geneva, World Health Organization, 2007
31. CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep
2010;59(No. RR-12).